 | • レポートコード：QFJ1-5942 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ペット用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗真菌剤、ノミ製品）、用途別市場規模（猫、犬、馬、魚、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ペット用医薬品の市場動向 ・企業の競争状況、市場シェア ・ペット用医薬品の種類別市場規模と予測2016-2027（抗生物質、抗真菌剤、ノミ製品） ・ペット用医薬品の用途別市場規模と予測2016-2027（猫、犬、馬、魚、その他） ・ペット用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・ペット用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペット用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペット用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペット用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Zoetis、Merck、Elanco、Bayer、Boehringer、Novartis、Virbac、Ceva、Vetoquinol、Nexvet、Aratana Therapeutics、Kindred Biosciences、Ambrx、Entest Biomedical、Taconic Biosciences） ・結論 |
Market Analysis and Insights: Global Pet Medication Market
The global Pet Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pet Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pet Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pet Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pet Medication market.
Global Pet Medication Scope and Market Size
Pet Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotics
Antifungal
Flea Products
Segment by Application
Cat
Dog
Horse
Fish
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Antifungal
1.2.4 Flea Products
1.3 Market by Application
1.3.1 Global Pet Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cat
1.3.3 Dog
1.3.4 Horse
1.3.5 Fish
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pet Medication Market Perspective (2016-2027)
2.2 Pet Medication Growth Trends by Regions
2.2.1 Pet Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pet Medication Historic Market Share by Regions (2016-2021)
2.2.3 Pet Medication Forecasted Market Size by Regions (2022-2027)
2.3 Pet Medication Industry Dynamic
2.3.1 Pet Medication Market Trends
2.3.2 Pet Medication Market Drivers
2.3.3 Pet Medication Market Challenges
2.3.4 Pet Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Medication Players by Revenue
3.1.1 Global Top Pet Medication Players by Revenue (2016-2021)
3.1.2 Global Pet Medication Revenue Market Share by Players (2016-2021)
3.2 Global Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pet Medication Revenue
3.4 Global Pet Medication Market Concentration Ratio
3.4.1 Global Pet Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Medication Revenue in 2020
3.5 Pet Medication Key Players Head office and Area Served
3.6 Key Players Pet Medication Product Solution and Service
3.7 Date of Enter into Pet Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Medication Breakdown Data by Type
4.1 Global Pet Medication Historic Market Size by Type (2016-2021)
4.2 Global Pet Medication Forecasted Market Size by Type (2022-2027)
5 Pet Medication Breakdown Data by Application
5.1 Global Pet Medication Historic Market Size by Application (2016-2021)
5.2 Global Pet Medication Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pet Medication Market Size (2016-2027)
6.2 North America Pet Medication Market Size by Type
6.2.1 North America Pet Medication Market Size by Type (2016-2021)
6.2.2 North America Pet Medication Market Size by Type (2022-2027)
6.2.3 North America Pet Medication Market Size by Type (2016-2027)
6.3 North America Pet Medication Market Size by Application
6.3.1 North America Pet Medication Market Size by Application (2016-2021)
6.3.2 North America Pet Medication Market Size by Application (2022-2027)
6.3.3 North America Pet Medication Market Size by Application (2016-2027)
6.4 North America Pet Medication Market Size by Country
6.4.1 North America Pet Medication Market Size by Country (2016-2021)
6.4.2 North America Pet Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pet Medication Market Size (2016-2027)
7.2 Europe Pet Medication Market Size by Type
7.2.1 Europe Pet Medication Market Size by Type (2016-2021)
7.2.2 Europe Pet Medication Market Size by Type (2022-2027)
7.2.3 Europe Pet Medication Market Size by Type (2016-2027)
7.3 Europe Pet Medication Market Size by Application
7.3.1 Europe Pet Medication Market Size by Application (2016-2021)
7.3.2 Europe Pet Medication Market Size by Application (2022-2027)
7.3.3 Europe Pet Medication Market Size by Application (2016-2027)
7.4 Europe Pet Medication Market Size by Country
7.4.1 Europe Pet Medication Market Size by Country (2016-2021)
7.4.2 Europe Pet Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pet Medication Market Size (2016-2027)
8.2 Asia-Pacific Pet Medication Market Size by Type
8.2.1 Asia-Pacific Pet Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pet Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pet Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific Pet Medication Market Size by Application
8.3.1 Asia-Pacific Pet Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pet Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pet Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific Pet Medication Market Size by Region
8.4.1 Asia-Pacific Pet Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pet Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pet Medication Market Size (2016-2027)
9.2 Latin America Pet Medication Market Size by Type
9.2.1 Latin America Pet Medication Market Size by Type (2016-2021)
9.2.2 Latin America Pet Medication Market Size by Type (2022-2027)
9.2.3 Latin America Pet Medication Market Size by Type (2016-2027)
9.3 Latin America Pet Medication Market Size by Application
9.3.1 Latin America Pet Medication Market Size by Application (2016-2021)
9.3.2 Latin America Pet Medication Market Size by Application (2022-2027)
9.3.3 Latin America Pet Medication Market Size by Application (2016-2027)
9.4 Latin America Pet Medication Market Size by Country
9.4.1 Latin America Pet Medication Market Size by Country (2016-2021)
9.4.2 Latin America Pet Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Medication Market Size (2016-2027)
10.2 Middle East & Africa Pet Medication Market Size by Type
10.2.1 Middle East & Africa Pet Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pet Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pet Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa Pet Medication Market Size by Application
10.3.1 Middle East & Africa Pet Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pet Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pet Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa Pet Medication Market Size by Country
10.4.1 Middle East & Africa Pet Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pet Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Medication Introduction
11.1.4 Zoetis Revenue in Pet Medication Business (2016-2021)
11.1.5 Zoetis Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Pet Medication Introduction
11.2.4 Merck Revenue in Pet Medication Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Elanco
11.3.1 Elanco Company Details
11.3.2 Elanco Business Overview
11.3.3 Elanco Pet Medication Introduction
11.3.4 Elanco Revenue in Pet Medication Business (2016-2021)
11.3.5 Elanco Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pet Medication Introduction
11.4.4 Bayer Revenue in Pet Medication Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Boehringer
11.5.1 Boehringer Company Details
11.5.2 Boehringer Business Overview
11.5.3 Boehringer Pet Medication Introduction
11.5.4 Boehringer Revenue in Pet Medication Business (2016-2021)
11.5.5 Boehringer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pet Medication Introduction
11.6.4 Novartis Revenue in Pet Medication Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Virbac
11.7.1 Virbac Company Details
11.7.2 Virbac Business Overview
11.7.3 Virbac Pet Medication Introduction
11.7.4 Virbac Revenue in Pet Medication Business (2016-2021)
11.7.5 Virbac Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Ceva Business Overview
11.8.3 Ceva Pet Medication Introduction
11.8.4 Ceva Revenue in Pet Medication Business (2016-2021)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Pet Medication Introduction
11.9.4 Vetoquinol Revenue in Pet Medication Business (2016-2021)
11.9.5 Vetoquinol Recent Development
11.10 Nexvet
11.10.1 Nexvet Company Details
11.10.2 Nexvet Business Overview
11.10.3 Nexvet Pet Medication Introduction
11.10.4 Nexvet Revenue in Pet Medication Business (2016-2021)
11.10.5 Nexvet Recent Development
11.11 Aratana Therapeutics
11.11.1 Aratana Therapeutics Company Details
11.11.2 Aratana Therapeutics Business Overview
11.11.3 Aratana Therapeutics Pet Medication Introduction
11.11.4 Aratana Therapeutics Revenue in Pet Medication Business (2016-2021)
11.11.5 Aratana Therapeutics Recent Development
11.12 Kindred Biosciences
11.12.1 Kindred Biosciences Company Details
11.12.2 Kindred Biosciences Business Overview
11.12.3 Kindred Biosciences Pet Medication Introduction
11.12.4 Kindred Biosciences Revenue in Pet Medication Business (2016-2021)
11.12.5 Kindred Biosciences Recent Development
11.13 Ambrx
11.13.1 Ambrx Company Details
11.13.2 Ambrx Business Overview
11.13.3 Ambrx Pet Medication Introduction
11.13.4 Ambrx Revenue in Pet Medication Business (2016-2021)
11.13.5 Ambrx Recent Development
11.14 Entest Biomedical
11.14.1 Entest Biomedical Company Details
11.14.2 Entest Biomedical Business Overview
11.14.3 Entest Biomedical Pet Medication Introduction
11.14.4 Entest Biomedical Revenue in Pet Medication Business (2016-2021)
11.14.5 Entest Biomedical Recent Development
11.15 Taconic Biosciences
11.15.1 Taconic Biosciences Company Details
11.15.2 Taconic Biosciences Business Overview
11.15.3 Taconic Biosciences Pet Medication Introduction
11.15.4 Taconic Biosciences Revenue in Pet Medication Business (2016-2021)
11.15.5 Taconic Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pet Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Antifungal
Table 4. Key Players of Flea Products
Table 5. Global Pet Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pet Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pet Medication Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pet Medication Market Share by Regions (2016-2021)
Table 9. Global Pet Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pet Medication Market Share by Regions (2022-2027)
Table 11. Pet Medication Market Trends
Table 12. Pet Medication Market Drivers
Table 13. Pet Medication Market Challenges
Table 14. Pet Medication Market Restraints
Table 15. Global Pet Medication Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pet Medication Market Share by Players (2016-2021)
Table 17. Global Top Pet Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Medication as of 2020)
Table 18. Ranking of Global Top Pet Medication Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pet Medication Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pet Medication Product Solution and Service
Table 22. Date of Enter into Pet Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pet Medication Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pet Medication Revenue Market Share by Type (2016-2021)
Table 26. Global Pet Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pet Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pet Medication Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pet Medication Revenue Market Share by Application (2016-2021)
Table 30. Global Pet Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pet Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pet Medication Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pet Medication Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pet Medication Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pet Medication Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pet Medication Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pet Medication Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pet Medication Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pet Medication Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pet Medication Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pet Medication Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pet Medication Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pet Medication Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pet Medication Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pet Medication Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pet Medication Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pet Medication Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pet Medication Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pet Medication Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pet Medication Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pet Medication Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pet Medication Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pet Medication Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pet Medication Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pet Medication Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pet Medication Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pet Medication Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pet Medication Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pet Medication Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pet Medication Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pet Medication Market Size by Country (2022-2027) & (US$ Million)
Table 62. Zoetis Company Details
Table 63. Zoetis Business Overview
Table 64. Zoetis Pet Medication Product
Table 65. Zoetis Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 66. Zoetis Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Pet Medication Product
Table 70. Merck Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Elanco Company Details
Table 73. Elanco Business Overview
Table 74. Elanco Pet Medication Product
Table 75. Elanco Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 76. Elanco Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Pet Medication Product
Table 80. Bayer Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Boehringer Company Details
Table 83. Boehringer Business Overview
Table 84. Boehringer Pet Medication Product
Table 85. Boehringer Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 86. Boehringer Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Pet Medication Product
Table 90. Novartis Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Virbac Company Details
Table 93. Virbac Business Overview
Table 94. Virbac Pet Medication Product
Table 95. Virbac Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 96. Virbac Recent Development
Table 97. Ceva Company Details
Table 98. Ceva Business Overview
Table 99. Ceva Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 100. Ceva Recent Development
Table 101. Vetoquinol Company Details
Table 102. Vetoquinol Business Overview
Table 103. Vetoquinol Pet Medication Product
Table 104. Vetoquinol Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 105. Vetoquinol Recent Development
Table 106. Nexvet Company Details
Table 107. Nexvet Business Overview
Table 108. Nexvet Pet Medication Product
Table 109. Nexvet Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 110. Nexvet Recent Development
Table 111. Aratana Therapeutics Company Details
Table 112. Aratana Therapeutics Business Overview
Table 113. Aratana Therapeutics Pet Medication Product
Table 114. Aratana Therapeutics Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 115. Aratana Therapeutics Recent Development
Table 116. Kindred Biosciences Company Details
Table 117. Kindred Biosciences Business Overview
Table 118. Kindred Biosciences Pet Medication Product
Table 119. Kindred Biosciences Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 120. Kindred Biosciences Recent Development
Table 121. Ambrx Company Details
Table 122. Ambrx Business Overview
Table 123. Ambrx Pet Medication Product
Table 124. Ambrx Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 125. Ambrx Recent Development
Table 126. Entest Biomedical Company Details
Table 127. Entest Biomedical Business Overview
Table 128. Entest Biomedical Pet Medication Product
Table 129. Entest Biomedical Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 130. Entest Biomedical Recent Development
Table 131. Taconic Biosciences Company Details
Table 132. Taconic Biosciences Business Overview
Table 133. Taconic Biosciences Pet Medication Product
Table 134. Taconic Biosciences Revenue in Pet Medication Business (2016-2021) & (US$ Million)
Table 135. Taconic Biosciences Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Medication Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Antifungal Features
Figure 4. Flea Products Features
Figure 5. Global Pet Medication Market Share by Application: 2020 VS 2027
Figure 6. Cat Case Studies
Figure 7. Dog Case Studies
Figure 8. Horse Case Studies
Figure 9. Fish Case Studies
Figure 10. Other Case Studies
Figure 11. Pet Medication Report Years Considered
Figure 12. Global Pet Medication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pet Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pet Medication Market Share by Regions: 2020 VS 2027
Figure 15. Global Pet Medication Market Share by Regions (2022-2027)
Figure 16. Global Pet Medication Market Share by Players in 2020
Figure 17. Global Top Pet Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Medication as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pet Medication Revenue in 2020
Figure 19. Global Pet Medication Revenue Market Share by Type (2016-2021)
Figure 20. Global Pet Medication Revenue Market Share by Type (2022-2027)
Figure 21. North America Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pet Medication Market Share by Type (2016-2027)
Figure 23. North America Pet Medication Market Share by Application (2016-2027)
Figure 24. North America Pet Medication Market Share by Country (2016-2027)
Figure 25. United States Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pet Medication Market Share by Type (2016-2027)
Figure 29. Europe Pet Medication Market Share by Application (2016-2027)
Figure 30. Europe Pet Medication Market Share by Country (2016-2027)
Figure 31. Germany Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pet Medication Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pet Medication Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pet Medication Market Share by Region (2016-2027)
Figure 41. China Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pet Medication Market Share by Type (2016-2027)
Figure 49. Latin America Pet Medication Market Share by Application (2016-2027)
Figure 50. Latin America Pet Medication Market Share by Country (2016-2027)
Figure 51. Mexico Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pet Medication Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pet Medication Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pet Medication Market Share by Country (2016-2027)
Figure 57. Turkey Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pet Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Zoetis Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 62. Elanco Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 64. Boehringer Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 66. Virbac Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 67. Ceva Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 68. Vetoquinol Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 69. Nexvet Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 70. Aratana Therapeutics Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 71. Kindred Biosciences Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 72. Ambrx Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 73. Entest Biomedical Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 74. Taconic Biosciences Revenue Growth Rate in Pet Medication Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界のCOPD用治療薬市場規模・現状・予測（2021年-2027年） Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matt…- 世界の投薬＆包装システム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Medication Dispensing and Packaging Systems Market The global Medication Dispensing and Packaging Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
- 世界の喘息/COPD併用薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Asthma/COPD Combination Medication Market The global Asthma/COPD Combination Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
- 世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年） Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief. Market Ana…
- 世界の心筋症治療薬市場規模・現状・予測（2021年-2027年） Cardiomyopathy is a group of diseases that affect the heart muscle. Early on there may be few or no symptoms. As the disease worsens, shortness of breath, feeling tired, and swelling of the legs may occur, due to the onset of heart failure. An irregular heart beat and fainting may occur. Those affec…